axatilimab-csfr

axatilimab-csfr (NIKTIMVO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

NIKTIMVO is a marketed brand name for axatilimab-csfr. Check FDA Drugs@FDA for the current US label holder and prescribing information.

axatilimab-csfr has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.